(Q54587377)

1 June 2018

title

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes. (English)

1 reference

1 June 2018

author

Wilfred F J van IJcken

10

1 reference

1 June 2018

Hanne Meijers-Heijboer

16

object named as

Hanne Meijers-Heijboer

1 reference

1 June 2018

Jord H A Nagel

1

1 reference

1 June 2018

Justine K Peeters

2

1 reference

1 June 2018

Marcel Smid

3

1 reference

1 June 2018

Anieta M Sieuwerts

4

1 reference

1 June 2018

Marijke Wasielewski

5

1 reference

1 June 2018

Vanja de Weerd

6

1 reference

1 June 2018

Anita M A C Trapman-Jansen

7

1 reference

1 June 2018

Ans van den Ouweland

8

1 reference

1 June 2018

Hennie Brüggenwirth

9

1 reference

1 June 2018

Jan G M Klijn

11

1 reference

1 June 2018

Peter J van der Spek

12

1 reference

1 June 2018

John A Foekens

13

1 reference

1 June 2018

John W M Martens

14

1 reference

1 June 2018

Mieke Schutte

15

1 reference

1 June 2018

language of work or name

English

0 references

publication date

26 May 2011

1 reference

1 June 2018

Breast Cancer Research and Treatment

published in

1 reference

1 June 2018

volume

132

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

439-448

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s10549-011-1588-x

exact match

0 references

cites work

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The genetic epidemiology of breast cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Ten genes for inherited breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The CHEK2 gene and inherited breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Breast cancer susceptibility-A new look at an old model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A genome wide linkage search for breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Identification of high risk breast-cancer patients by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Genetic regulators of large-scale transcriptional signatures in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

RecQ helicases: caretakers of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The Bloom's syndrome gene product is homologous to RecQ helicases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Positional cloning of the Werner's syndrome gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

BRCA1 supports XIST RNA concentration on the inactive X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

X chromosomal abnormalities in basal-like human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The DNA damage response: putting checkpoints in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

CHK2 kinase--a busy messenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Is TP53 dysfunction required for BRCA1-associated carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1588-X

10.1007/S10549-011-1588-X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21614566

1 reference

1 June 2018